Oncology Target Discovery by RNAi: The past, present, and future perspectives
Posted in Archive
| Tagged Academic, AI / data analytics / healthtech / informatics, Analysis, Analytical chemistry, Assay development optimisation & technology, Biochemistry, Business, Cell culture, Cell therapy, Cellular & Molecular biology, Chemical engineering, Chemistry, Clinical specialities, Clinical trials, Combinatorial chemistry, Computational chemistry, Drug development, Drug discovery, Drug targets, Enabling technologies, Gene editing, Gene therapy, Genetics / genomes, Genetics / genomics, Genomics, High Content Screening, High throughput screening, Lead discovery, Lead optimisation, Molecular medicine, Oncology, PCR, Pharmacology, Preclinical, Protein chemistry / Proteomics, Regulatory, RNA, Screening, Sequencing, Stem cells, System biology, Systems biology, Target validation, Therapeutics, Translational, Translational chemistry
